Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fenge

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cytotechnology|May 1, 1991
On-line monitoring of monoclonal antibody formation in high density perfusion culture using FIAC Fenge, E Fraune, R Freitag, et al.
Cytotechnology|January 1, 1993
Agitation, aeration and perfusion modules for cell culture bioreactorsC Fenge, C Klein, C Heuer, et al.
Biotechnology Progress|February 8, 2003
Comparison of batch and perfusion culture in combination with pilot-scale expanded bed purification for the production of soluble recombinant beta-secretaseE Lüllau, A Kanttinen, J Hassel, et al.
Seminars in Hematology|July 13, 2001
The manufacturing process for B-domain deleted recombinant factor VIIIR K Eriksson, C Fenge, E Lindner-Olsson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2011
Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC projectC A González, F Megraud, A Buissonniere, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cytotechnology|May 1, 1991
On-line monitoring of monoclonal antibody formation in high density perfusion culture using FIAC Fenge, E Fraune, R Freitag, et al.
Cytotechnology|January 1, 1993
Agitation, aeration and perfusion modules for cell culture bioreactorsC Fenge, C Klein, C Heuer, et al.
Biotechnology Progress|February 8, 2003
Comparison of batch and perfusion culture in combination with pilot-scale expanded bed purification for the production of soluble recombinant beta-secretaseE Lüllau, A Kanttinen, J Hassel, et al.
Seminars in Hematology|July 13, 2001
The manufacturing process for B-domain deleted recombinant factor VIIIR K Eriksson, C Fenge, E Lindner-Olsson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2011
Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC projectC A González, F Megraud, A Buissonniere, et al.
Pageof 1